Treprostinil IV or SC

Treprostinil IV or SC

Form: SC or Intravenous (IV)

Strength: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)

Reference Brands: Remodulin®(US & EU)

Category: Orphan Drugs

Treprostinil, marketed as Remodulin®, is approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include comprehensive clinical data, manufacturing standards, and safety profiles submitted to FDA and EMA, supporting its approval for subcutaneous and intravenous use. The product is used for continuous infusion to improve exercise capacity and reduce symptoms. Dossiers demonstrate high-quality manufacturing and proven efficacy. For detailed insights on regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory updates and industry insights.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Galsulfase IV

Strength: 1mg/ml

Form: Lyophilized powder for IV

Reference Brands: Vimizim®(US & EU)

View Details Get Enquiry
Alglucosidase Alfa IV

Strength: 50 mg/vial

Form: Lyophilized powder

Reference Brands: Lumizyme®(US & EU)

View Details Get Enquiry
Nitisinone tablets

Strength: 2 mg and 5 mg

Form: Tablets

Reference Brands: Orfadin®

View Details Get Enquiry
Iloprost inahalation Solution

Strength: 10 mcg/mL

Form: Inhalation Solution (Nebulizer)

Reference Brands: Ventavis®(EU & US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.